Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE)

BACKGROUND: Fidaxomicin, a narrow-spectrum antibiotic approved for Clostridioides (Clostridium) difficile infection (CDI) in adults, is associated with lower rates of recurrence than vancomycin; however, pediatric data are limited. This multicenter, investigator-blind, phase 3, parallel-group trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Joshua, Kalocsai, Krisztina, Fortuny, Claudia, Lazar, Stefan, Bosis, Samantha, Korczowski, Bartosz, Petit, Arnaud, Bradford, Daniel, Croos-Dabrera, Rodney, Incera, Elodie, Melis, Joost, van Maanen, Rob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744996/
https://www.ncbi.nlm.nih.gov/pubmed/31773143
http://dx.doi.org/10.1093/cid/ciz1149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744996/
https://www.ncbi.nlm.nih.gov/pubmed/31773143
http://dx.doi.org/10.1093/cid/ciz1149

Ejemplares similares